Trials / Suspended
SuspendedNCT01990326
Safety and Feasibility Study of XAF5 Gel for Reduction of Submental Fat
A Phase 2a, Randomized, Double-blind, Placebo-controlled Study of XAF5 Gel for Reduction of Submental Fat
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Topokine Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will test the effects of XAF5 Gel (applied to skin each night for 6 weeks) on excess submental fat, also known as double chin. The study will also assess the safety and tolerability of XAF5 Gel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | XAF5 Gel | |
| DRUG | Placebo Gel |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- First posted
- 2013-11-21
- Last updated
- 2016-02-29
Source: ClinicalTrials.gov record NCT01990326. Inclusion in this directory is not an endorsement.